Biologics Corp

Executive Summary

Biologics Corp (Biologics International Corp) is a US-based CRO/CDMO headquartered in San Diego, founded in 2005. The company specializes in custom recombinant protein and antibody production services, including expression system optimization, antibody engineering, stable cell line construction, and biomolecular interaction analysis. Serving academic and biopharmaceutical clients globally, Biologics Corp benefits from the increasing outsourcing trend in biologics development and manufacturing. While privately held and lacking public financial disclosures, the company's established track record and broad service portfolio position it well within the competitive CRO/CDMO market. Strategic investments in capacity expansion and technology innovation are expected to drive growth, though visibility into near-term performance is limited.

Upcoming Catalysts (preview)

• Q4 2026Expansion of GMP Manufacturing Capacity70% success
• Q2 2027Launch of Novel High-Yield Expression Platform60% success
• Q3 2026Preferred Provider Agreement with Top-20 Pharma50% success